Come up with a name for your new list and we'll add to it:
Augmenix was acquired by
Boston Scientific Corporation on September 06, 2018.
Augmenix is a privately held medical device company developing in-situ formed, space-filling hydrogels specifically for radiation oncology and cancer surgery indications. Augmenix's initial product wi…